The Motley Fool on MSN
Teva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock.
That's when its first-quarter results will be published.
Zacks Investment Research on MSN
Teva stock up more than 100% in a year: Time to buy, hold or sell?
Teva Pharmaceutical Industries Limited’s TEVA stock has risen 102.8% in the past year, fueled by strong revenue and earnings ...
Those who do not learn from history are doomed to repeat it. That feels awfully applicable when talking about Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). Teva Pharmaceutical Industries Ltd ...
Big developments are coming out of Teva Pharmaceuticals (TEVA) this week. Some could either be the generic giant's saving grace while others could sink the company. Let's deal with these from last to ...
Teva Pharmaceutical Industries, an Israel-based generic drugmaker, surprised the drug industry by requesting to join the Pharmaceutical Research and Manufacturers of America, a powerful trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results